Industry Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Times of New York.

Press releases published on March 8, 2026

Mar. 8, 2026

Advanced eClinical Training Expands Nationwide Clinical Partner Network, Strengthening Medical Assistant Pipeline

Indeterminate EIN Presswire

Mar. 8, 2026

CLASS ACTION INVESTOR ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BlackRock TCP and Plug Power and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Mar. 8, 2026

PICARD MEDICAL STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Picard Medical, Inc. and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Mar. 8, 2026

ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights

Indeterminate GlobeNewswire

Mar. 8, 2026

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Indeterminate GlobeNewswire

Mar. 8, 2026

Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against NuScale Power Corporation, Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

Indeterminate GlobeNewswire

Mar. 8, 2026

ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Hub Group, Inc. Investors to Inquire About Securities Class Action Investigation – HUBG

Indeterminate GlobeNewswire

Mar. 8, 2026

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Lakeland Industries, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Plug Power Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges AMC Entertainment Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges BellRing Brands, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges China Liberal Education Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Franklin BSP Realty Trust, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

Mar. 8, 2026

EDR IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endeavor Group Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 18 Deadline in Securities Class Action - EDR

Indeterminate GlobeNewswire